(3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine
C20H18F3N7O — CID 168678888
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine
(3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine (PubChem CID 168678888) has the molecular formula C20H18F3N7O and a molecular weight of 429.41 g/mol. Its IUPAC name is (3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine.
Molecular Properties
| Compound Name | (3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine |
|---|---|
| PubChem CID | 168678888 |
| Molecular Formula | C20H18F3N7O |
| Molecular Weight | 429.41 g/mol |
| Exact Mass | 429.15 |
| IUPAC Name | (3R)-3-methyl-4-[3-(1H-pyrazol-5-yl)-7-[2-(trifluoromethyl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidin-5-yl]morpholine |
| SMILES | C[C@@H]1COCCN1c1cc(-c2cccnc2C(F)(F)F)n2ncc(-c3ccn[nH]3)c2n1 |
| InChI | InChI=1S/C20H18F3N7O/c1-12-11-31-8-7-29(12)17-9-16(13-3-2-5-24-18(13)20(21,22)23)30-19(27-17)14(10-26-30)15-4-6-25-28-15/h2-6,9-10,12H,7-8,11H2,1H3,(H,25,28)/t12-/m1/s1 |
| InChIKey | ZQHYMLVDLNNXMY-GFCCVEGCSA-N |
| XLogP | 3.43 |
| TPSA | 84.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.41 |
| LogP ≤ 5 | 3.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168678888 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.